0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Vitronectin

Vitronectin

Brief Information

Name:Vitronectin
Target Synonym:Vitronectin,V75,VN,Serum-spreading factor,Vitronectin (Serum Spreading Factor, Somatomedin B, Complement S-Protein),Somatomedin B,Epibolin,Serum Spreading Factor,VNT,S-protein,Complement S-Protein,Protein S
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Preclinical

Product ListCompare or Buy

Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
VIN-H5214 Human Human Vitronectin / VTN Protein, Tag Free
VIN-H5214-structure
VIN-H5214-sds
VIN-H5117 Human Human Truncated Vitronectin / VTN-N Protein, premium grade
VIN-H5117-structure
ACRO Quality

Part of Bioactivity data

VIN-H5214-MALS-HPLC
 Vitronectin ELISA

Immobilized Human Vitronectin Protein, Tag Free (Cat. No. VIN-H5214) at 5 μg/mL (100 μL/well) can bind Biotinylated Mouse ITGAV&ITGB3 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT3-H82W3) with a linear range of 0.002-0.156 μg/mL (QC tested).

Synonym Name

VTN,V75,VN,Vitronectin,S-protein,Serum-spreading factor

Background

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.

Clinical and Translational Updates

This web search service is supported by Google Inc.

totop

Laisser un message